CESAR L ALVAREZ
CIK 1220297 · last filed 2026-03-16
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$5.17M
Companies
7
Total Filings
70
Lifetime Open-Market Net
-$12.50M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PGEN | Director | 782,909 | $4.45 | $3.48M | $0 | 15 | 2026-03-16 |
| WSO.B | Director | 0 | $350.00 | $0 | -$5.46M | 8 | 2025-03-07 |
| MD | Director | 48,403 | $24.30 | $1.18M | -$7.13M | 19 | 2020-02-18 |
| PRECIGEN, INC. (XON) Delisted | Director | 125,368 | — | — | $0 | 18 | 2019-03-26 |
| JOE | Director | 4,700 | $64.92 | $305.1K | $89.8K | 5 | 2018-03-19 |
| PDX | Director | 10,000 | $20.85 | $208.5K | $0 | 4 | 2008-05-23 |
| NEW RIVER PHARMACEUTICALS INC (NRPH) Delisted | Director | — | — | — | $0 | 1 | 2007-01-31 |
Recent Filings · Page 7 of 7
70 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2011-05-05 | MD | Grant (A) | — | $0 | EDGAR |
| 2010-05-07 | MD | Grant (A) | — | $0 | EDGAR |
| 2009-05-07 | MD | Grant (A) | — | $0 | EDGAR |
| 2008-05-23 | PDX | Grant (A) | — | $0 | EDGAR |
| 2007-11-02 | PDX | Grant (A) | — | $0 | EDGAR |
| 2007-11-02 | PDX | Grant (A) | — | $0 | EDGAR |
| 2007-08-23 | WSO.B | Exer (M) | +30,000 | $456.9K | EDGAR |
| 2007-02-23 | PDX | Exer (M) | +10,000 | $163.1K | EDGAR |
| 2007-02-22 | WSO.B | Exer (M) | +25,313 | $474.6K | EDGAR |
| 2007-01-31 | NEW RIVER PHARMACEUTICALS INC (NRPH) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 61–70 of 70
Prev
Page 7 of 7
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.